CHM chimeric therapeutics limited

Ann: CHM CDH17 ADVANCES TO DOSE LEVEL 2, page-22

  1. 3,147 Posts.
    lightbulb Created with Sketch. 1759
    Reading the Quarterly - Patient 5 had already had their manufacturing run completed by the 31st March so that's been paid for as well.

    So that only leaves two patients that require their manufacturing run which equates to around $1.5 million.

    Having said that - This post from Linkedin was from two weeks ago.

    https://hotcopper.com.au/data/attachments/7015/7015253-5a9ee6752bbfc0f016fb66b0728b3fe4.jpg
    So by all accounts that should be patient six or seven's manufacturing run? Paid for already? Have shareholders been updated on this?

    So many unanswered questions! So few answers.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.